KEGG   DRUG: EnfuvirtideHelp
Entry
D02499                      Drug                                   

Name
Enfuvirtide (USAN/INN);
Fuzeon (TN)
Product
Formula
C204H301N51O64
Exact mass
4489.1866
Mol weight
4491.876
Sequence
Ac-Tyr Thr Ser Leu Ile His Ser Leu Ile Glu Glu Ser Gln Asn Gln Gln
Glu Lys Asn Glu Gln Glu Leu Leu Glu Leu Asp Lys Trp Ala Ser Leu
Trp Asn Trp Phe-NH2
  Type
Peptide
Remark
ATC code: J05AX07
Product: D02499<US>
Efficacy
Antiviral, gp-41 fusion inhibitor
  Disease
HIV-1 infection [DS:H01563]
Target
HIV glycoprotein 41 (gp41)
Interaction
Drug interaction
Structure map
map07053  Anti-HIV agents
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 J ANTIINFECTIVES FOR SYSTEMIC USE
  J05 ANTIVIRALS FOR SYSTEMIC USE
   J05A DIRECT ACTING ANTIVIRALS
    J05AX Other antivirals
     J05AX07 Enfuvirtide
      D02499  Enfuvirtide (USAN/INN) <US>
USP drug classification [BR:br08302]
 Antivirals
  Anti-HIV Agents, Other
   Enfuvirtide
    D02499  Enfuvirtide (USAN/INN)
Antiinfectives [br08350.html]
 Antivirals
  D02499
New drug approvals in the USA [br08319.html]
 New Molecular Entity and New Therapeutic Biological Product Approvals
  D02499
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D02499
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D02499
BRITE hierarchy
Other DBs
CAS: 159519-65-0
PubChem: 17396673
ChEBI: 608828
DrugBank: DB00109
NIKKAJI: J2.173.441A
LinkDB All DBs

» Japanese version   » Back

DBGET integrated database retrieval system